Abstract
Aim: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). Methods: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Results: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Conclusions: Early treatment with DAA should be offered when available.
Original language | English |
---|---|
Pages (from-to) | 183-188 |
Number of pages | 6 |
Journal | Infection |
Volume | 46 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 1 2018 |
Keywords
- Acute hepatitis C
- Direct-acting antivirals
- Peginterferon
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases